APA (7th ed.) Citation

Fazio, S., & Bellavite, P. (2023). Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin. BioMed, 3(1), 177. https://doi.org/10.3390/biomed3010015

Chicago Style (17th ed.) Citation

Fazio, Serafino, and Paolo Bellavite. "Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin." BioMed 3, no. 1 (2023): 177. https://doi.org/10.3390/biomed3010015.

MLA (9th ed.) Citation

Fazio, Serafino, and Paolo Bellavite. "Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin." BioMed, vol. 3, no. 1, 2023, p. 177, https://doi.org/10.3390/biomed3010015.